Replicate Bioscience logo

Replicate Bioscience Funding & Investors

Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of drug resistance and create solutions that enhance the effectiveness of many immuno-oncology regimens.

replicatebioscience.com

Total Amount Raised: $46,000,000

Replicate Bioscience Funding Rounds

  • Series A

    $40,000,000

    Series A Investors

    Apple Tree Partners
  • Seed

    $6,000,000

    Seed Investors

    Apple Tree Partners
Funding info provided by Diffbot.